Optimal encephalitis/meningitis roadmap via precise diagnosis and treatment (IMPROVE): a study protocol for a randomized controlled trial

BACKGROUND: Encephalitis/meningitis brings a heavy disease burden, and the origin of disease remains unknown in 30–40% of patients. It is greatly significant that combinations of nucleic acid amplification and autoimmune antibody testing improves the diagnosis and treatment of encephalitis/meningiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi, Zhang, Haocheng, Deng, Bo, Lin, Ke, Jin, Lei, Liu, Xiaoni, Zhang, Yanlin, Chen, Xiaohua, Zhang, Yanliang, Lu, Shengjia, Huang, Heqing, Wang, Qiujing, Feng, Tingting, Zhao, Weifeng, Xue, Qun, Chen, Renfang, Zhang, Jingbo, Qian, Xiaoyan, Chen, Lanlan, Ai, Jingwen, Chen, Xiangjun, Zhang, Wenhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742395/
https://www.ncbi.nlm.nih.gov/pubmed/34998377
http://dx.doi.org/10.1186/s12879-021-06943-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742395/
https://www.ncbi.nlm.nih.gov/pubmed/34998377
http://dx.doi.org/10.1186/s12879-021-06943-6

Ejemplares similares